[1] Wu ZY. New situation and challenge of HIV/AIDS prevention in China. Chin J Public Health 2011;27(12):1505 − 7. http://dx.doi.org/10.11847/zgggws2011-27-12-01 (In Chinese). CrossRef
[2] Zhang YW, Cai C, Wang XF, Li YF, Tang HL, Ma JQ. Preplanned studies: disproportionate increase of new diagnosis of HIV/AIDS infection by sex and age — China, 2007−2018. China CDC Wkly 2020;2(5):69 − 74. http://dx.doi.org/10.46234/ccdcw2020.020CrossRef
[3] Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996;124(7):654 − 63. http://dx.doi.org/10.7326/0003-4819-124-7-199604010-00006CrossRef
[4] Wu ZY. HIV/AIDS prevention strategy with Chinese characteristics. Chin J Dis Control Prev 2019;23(8):885 − 9. http://dx.doi.org/10.16462/j.cnki.zhjbkz.2019.08.001 (In Chinese). CrossRef
[5] Ge L, Li DM, Li PL, Qu SQ, Chen FF, Lyu F. Preplanned studies: HIV and HCV infection status among drug users-China, 2010-2018. China CDC Wkly 2020;2(7):109 − 12. http://dx.doi.org/10.46234/ccdcw2020.031CrossRef
[6] Ge L, Cui Y, Wang L, Li DM, Guo W, Ding ZW, et al. Study on the characteristics of serology and sexual behavior among drug users at the HIV sentinel surveillance sites in 2012. Chin J Epidemiol 2014;35(2):121 − 3. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2014.02.004 (In Chinese). CrossRef
[7] National Center for AIDS/STD Control and Prevention, China CDC. National HIV/syphilis/HCV sentinel surveillance report in 2019. Beijing; 2020.
[8] Duan S, Yang YC, Han J, Yang SS, Yang YB, Long YC, et al. Study on incidence of HIV infection among heroin addicts receiving methadone maintenance treatment in Dehong prefecture, Yunnan province. Chin J Epidemiol 2011;32(12):1227 − 31. http://dx.doi.org/10.3760/cma.j.issn.0254-6450.2011.12.011 (In Chinese). CrossRef